This guideline was developed before the COVID-19 pandemic. It covers diagnosing and managing pneumonia in adults who do not have COVID-19. It aims to improve accurate assessment and diagnosis of pneumonia to help guide antibiotic prescribing and ensure that people receive the right treatment.
July 2022:...
Las leishmaniasis son enfermedades infecciosas desatendidas de gran importancia en la Región de las Américas debido a su morbilidad, mortalidad y amplia distribución geográfica. De las tres formas clínicas principales, la cutánea es la más común y la visceral es la forma más grave, ya que puede ...
Leishmaniasis/tratamiento farmacológico,
Leishmaniasis/prevención & control,
Antiprotozoarios/uso terapéutico,
Américas,
Leishmaniasis Visceral/tratamiento farmacológico,
Leishmaniasis Mucocutánea/tratamiento farmacológico,
Leishmaniasis Cutánea/tratamiento farmacológico,
Enfermedades Desatendidas/tratamiento farmacológico,
Prevención de Enfermedades,
Hipertermia Inducida/métodos,
Paromomicina/uso terapéutico
The leishmaniases are a group of diseases caused by Leishmania spp., which occur in cutaneous, mucocutaneous and visceral forms. They are neglected tropical diseases (NTDs), which disproportionately affect marginalized populations who have limited access to health care. HIV co-infected patients with Leis...
This guideline aims to increase the uptake of all vaccines provided on the NHS routine UK immunisation schedule by everyone who is eligible. It supports the aims of the NHS Long Term Plan, which includes actions to improve immunisation coverage by GPs (including the changes to vaccinations and immunisati...
